Patent Assignment
Reel/Frame 020700/0750
Change of Name
Recorded: 2008-03-26
Pages: 4
Assignor
ATUGEN AG (AKTIENGESELLSCHAFT)
Executed: 2007-07-10
Assignee
SILENCE THERAPEUTICS AKTIENGESELLSCHAFT (AG)
ROBERT-ROSSLE-STRASSE 10, BERLIN, 13125, GERMANY
Covered Properties
(5)
Compounds and Methods for the Identification and/ or Validation of a Target
Application:
10/336,855 →
Publication:
US 2003/0135033
Factor involved in metastasis and uses thereof
Application:
10/531,726 →
Publication:
US 2006/0240022
Interfering Rna Molecules
Further Use of Protein Kinase N Beta
Use of double-stranded ribonucleic acid for inducing cell lysis
Application:
10/876,779 →
Publication:
US 2005/0043263
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 26, 2003
From: KLIPPEL-GIESE, ANKE; KAUFMANN, JORG; GIESE, KLAUS
To: ATUGEN AG
Reel/Frame 013905/0299 →
Assignment of Assignor's Interest
Jan 20, 2004
From: KLIPPEL-GIESE, ANKE; KAUFMANN, JOERG
To: ATUGEN AG
Reel/Frame 014905/0222 →
Assignment of Assignor's Interest
Feb 4, 2004
From: GIESE, KLAUS; KAUFMANN, JOERG; KLIPPEL-GIESE, ANKE
To: ATUGEN AG
Reel/Frame 014958/0009 →
Assignment of Assignor's Interest
Oct 25, 2004
From: GIESE, KLAUS; KAUFMANN, JOERG
To: ATUGEN AG
Reel/Frame 015287/0786 →
Assignment of Assignor's Interest
Mar 9, 2006
From: KLIPPEL-GIESE, ANKE; KAUFMANN, JOERG; SCHWARZER, ROLF
To: ATUGEN AG
Reel/Frame 017282/0672 →
Change of Name
Jan 15, 2015
From: SILENCE THERAPEUTICS AG
To: SILENCE THERAPEUTICS GMBH
Reel/Frame 034767/0324 →